{"id":3642,"date":"2026-09-10T15:36:27","date_gmt":"2026-09-10T15:36:27","guid":{"rendered":"https:\/\/drsoniafawad.com\/?p=3642"},"modified":"2026-09-10T15:36:27","modified_gmt":"2026-09-10T15:36:27","slug":"cancer-screening-lower-among-adults-with-disabilities","status":"publish","type":"post","link":"https:\/\/drsoniafawad.com\/?p=3642","title":{"rendered":"Cancer screening lower among adults with disabilities"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div data-component=\"ArticleContent\">\n<div class=\"article__below-title\">\n<div class=\" article__posted-date\">\n<p>September 10, 2026<\/p>\n<p>6 min read<\/p>\n<\/p><\/div>\n<div class=\"mobile-trust-box\">\n<div class=\"row\">\n<div class=\"col-12 col-md-5 d-xl-none\">\n<div class=\"trust-box\">\n<div class=\"trust-box-logo d-none d-md-block\">\n            <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hot.svg?la=en&amp;h=24&amp;w=141&amp;hash=2F86D471C8514C0E334E329AA799E8B4\" class=\"logo-img\" height=\"24\" alt=\"hemonc today logo\" width=\"141\"\/>\n          <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"col-12 col-md-6 offset-md-1 offset-xl-0 col-xl-12\">\n<div class=\"email-alert-button-wrapper d-none\" data-component=\"EmailTopicAlert\" data-module=\"Subspecialty Email Topic Alerts Top\" data-manage-email-link=\"\/footer\/account-information\/my-account\/email-subscriptions-and-alerts#emailAlerts\">\n  <hidden data-setting-item=\"d265901d-6d37-49c7-a8f6-c7bf19a02509\"\/><br \/>\n  <hidden data-crm-source=\"Subspecialty Topic Alert\"\/><\/p>\n<div class=\"email-alert-button d-none\" data-topic-button=\"not-subscribed\">\n<p>&#13;<br \/>\n      <span data-module-track-action=\"Email Alerts TOP_Click_Healio News Article\" data-module-track-label=\"Email Alerts TOP_Healio News Article\">&#13;<br \/>\n        <i class=\"fas fa-plus-circle\"\/>&#13;<br \/>\n        Add topic to email alerts&#13;<br \/>\n      <\/span>&#13;\n    <\/p>\n<div class=\"email-alert-inner collapse u483252c67cd74a549285394306c311e2\">\n<div class=\"email-alert-dialogue\">\n<p>&#13;<br \/>\n          Receive an email when new articles are posted on <span data-content=\"topic-title\"\/>&#13;\n        <\/p>\n<div class=\"d-none\" data-sign-up-type=\"unknown\">\n          Please provide your email address to receive an email when new articles are posted on <span data-content=\"topic-title\"\/>.<\/p><\/div>\n<\/p><\/div>\n<p>      <button type=\"button\" class=\"btn btn-primary\" data-loading-text=\"Loading &lt;i class=\" fa=\"\" fa-spinner=\"\" fa-spin=\"\">&#8220;&#13;<br \/>\n              data-action=&#8221;subscribe&#8221;&gt;&#13;<br \/>\n        Subscribe&#13;<br \/>\n      <\/button>\n    <\/div>\n<\/p><\/div>\n<div class=\"d-none\" data-topic-modal=\"failed\">    <strong>We were unable to process your request. Please try again later. If you continue to have this issue please contact <a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260910\/mailto:customerservice@slackinc.com\">customerservice@slackinc.com<\/a>.<\/strong>  <\/p>\n<p><button data-dismiss=\"modal\" class=\"btn btn-primary btn-lg btn-block\">Back to Healio<\/button><\/p>\n<\/div>\n<\/div><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<h2>Key takeaways:<\/h2>\n<ul>\n<li>Adults with disabilities are significantly less likely to undergo routine cancer screenings.<\/li>\n<li>The largest gaps exist for those with self-care disabilities and those with greater disability-related difficulty.<\/li>\n<\/ul>\n<p>U.S. adults with disabilities are considerably less likely than those without them to undergo routine cancer screening, according to an analysis of national survey data.<\/p>\n<p>Researchers observed the largest screening gaps among individuals with self-care disabilities, such as difficulty dressing or bathing.<\/p>\n<figure class=\"figure article__og-image\">&#13;\n    <picture>&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/09_september\/hot0926mazzitelli_graphic_01.webp?w=476\" media=\"(max-width: 768px)\">&#13;<source srcset=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/09_september\/hot0926mazzitelli_graphic_01.webp?w=800\" media=\"(max-width: 992px)\">&#13;<source srcset=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/09_september\/hot0926mazzitelli_graphic_01.webp?w=595\" media=\"(max-width: 1200px)\">&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/09_september\/hot0926mazzitelli_graphic_01.webp?w=476\" media=\"(min-width: 1200px)\">&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/09_september\/hot0926mazzitelli_graphic_01.webp?w=476\">&#13;<br \/>\n&#13;<br \/>\n      <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/09_september\/hot0926mazzitelli_graphic_01.jpg?w=800\" alt=\"HGI0926Mazzitelli\" class=\"figure-img img-fluid\" width=\"800\"\/>&#13;<br \/>\n    <\/source><\/source><\/source><\/source><\/source><\/picture>&#13;<figcaption class=\"figure-caption\">&#13;<br \/>\n      Data derived from Mazzitelli N, et al. Cancer. 2026;doi:10.1002\/cncr.70557.&#13;<br \/>\n    <\/figcaption>&#13;<br \/>\n  <\/figure>\n<p>Screening prevalence also declined as disability-related difficulty levels increased.<\/p>\n<p>For example, adults who reported \u201csubstantial\u201d difficulties with self-care appeared 37% less likely to undergo <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260216\/us-women-favor-inclinic-cervical-cancer-screening-over-athome-test\" id=\"rId12\" target=\"_blank\">cervical cancer screening<\/a> and 31% less likely to undergo <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260714\/civically-engaged-women-more-likely-to-undergo-breast-cancer-screening\" id=\"rId13\" target=\"_blank\">breast cancer screening<\/a> than adults with no difficulty. Screening also declined with greater difficulty in other disability domains, such as cognition, mobility and vision.<\/p>\n<div class=\"mug left\"><img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/mugs\/b\/bandi_priti_2026.jpg\" width=\"80\" height=\"106\" alt=\"\" style=\"height: 106px; width: 80px;\"\/><\/p>\n<p><strong>Priti Bandi, PhD<\/strong><\/p>\n<\/div>\n<p>The findings are \u201ccause for alarm,\u201d according to senior author <b>Priti Bandi, PhD<\/b>, scientific director for cancer risk factors and screening surveillance research at American Cancer Society.<\/p>\n<p>\u201cWe know individuals with disabilities tend to have lower access to healthcare, but the magnitude of the disparities we observed \u2014 and the consistency with which they showed up across different domains \u2014 really surprised me,\u201d Bandi told Healio. \u201cBeing able to document this represents a call to action. This needs to be addressed.\u201d<\/p>\n<h2>\u2018A clearer picture\u2019<\/h2>\n<p>More than one in four adults in the United States have some type of disability, according to CDC statistics.<\/p>\n<p>The most prevalent disabilities are those that affect cognition (13.9%), mobility (12.2%), independent living (7.7%), hearing (6.2%), vision (5.5%) and self-care (3.6%).<\/p>\n<p>All-cause mortality risk is more than double among individuals with disabilities than without, and risk for death due to chronic conditions \u2014 including cancer \u2014 also is higher, according to study background.<\/p>\n<p>Prior research showed people with cognitive, mobility or intellectual disabilities are less adherent to cancer screening. This may be due to barriers related to clinic access (eg, lack of transportation or insurance), personal factors (eg, fear of embarrassment or distrust of the medical system) or difficulties completing the physical aspects of screening, Bandi said.<\/p>\n<p>However, evidence about how adherence varies based on disability domains and related difficulty is limited.<\/p>\n<p>\u201cHaving a clearer picture about how disabilities impact receipt of cancer preventive services across disability domains \u2014 not just physical, but also the more \u2018invisible\u2019 disabilities related to cognition and communication \u2014 is critical to help develop interventions that are relevant and effective for these populations,\u201d Bandi said.<\/p>\n<p>Bandi and colleagues \u2014 including lead author <b>Natalia Mazzitelli, MPH<\/b> \u2014 evaluated self-reported adherence to U.S. Preventive Services Task Force recommendations for breast, cervical and <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260527\/guideline-update-underscores-importance-of-options-for-colorectal-cancer-screening\" id=\"rId14\" target=\"_blank\">colorectal cancer screening<\/a> among adults with disabilities vs. those without, calculating adjusted prevalence ratios (aPR) to make the comparisons.<\/p>\n<p>The researchers pooled data from the National Health Interview Survey in 2021 and 2023. Each survey collected a broad range of data about health topics from more than 29,000 noninstitutionalized adults.<\/p>\n<p>Investigators assessed self-reported screening rates based on six functioning domains \u2014 vision, hearing, mobility, communication, cognition and self-care.<\/p>\n<p>Because there often is overlap between domains, researchers analyzed the degree of difficulty for each one \u2014 using the Washington Group Composite Disability Indicator, a validated tool that classifies severity of functional limitations \u2014 to further clarify individuals at greatest risk for screening nonadherence.<\/p>\n<h2>Key findings<\/h2>\n<p>The researchers identified survey respondents with disabilities eligible for breast screening (n = 1,712; population weighted, n = 6.02 million), cervical screening (n = 1,147, population weighted, n = 5.1 million) and colorectal screening (n = 3,106; population weighted, n = 11.17 million).<\/p>\n<p>Results revealed the following trends by screening type:<\/p>\n<ul>\n<li>      <b>Breast cancer:<\/b> Eligible adults with \u201csubstantial\u201d difficulties across multiple disability domains had lower screening prevalence than those who reported no difficulties, with the lowest prevalence in the self-care (52% vs. 79%; aPR = 0.69; 95% CI, 0.58-0.82), vision (62% vs. 79%; aPR = 0.83; 95% CI, 0.75-0.91) and mobility (68% vs. 79%; aPR = 0.89; 95% CI, 0.85-0.93) domains. Results showed significantly lower screening prevalence among those with \u201csome\u201d difficulties vs. no difficulty in self-care (71% vs. 79%; aPR = 0.93; 95% CI, 0.88-0.99), cognition (75% vs. 79%; aPR = 0.96; 95% CI, 0.94-0.99) and vision (75% vs. 79%; aPR = 0.96; 95% CI, 0.94-0.99).<\/li>\n<li>      <b>Cervical cancer:<\/b> Eligible adults who reported \u201csubstantial\u201d difficulties across multiple disability domains had lower screening prevalence than those who reported no difficulties, with the lowest prevalence in the self-care (37% vs. 78%; aPR = 0.63; 95% CI, 0.51-0.78), vision (64% vs. 78%; aPR = 0.89; 95% CI, 0.8-0.98), mobility (65% vs. 78%; aPR = 0.88; 95% CI, 0.82-0.94) and cognitive (64% vs. 78%; aPR = 0.91; 95% CI, 0.85-0.98) domains. Results showed significantly lower screening prevalence among those with \u201csubstantial\u201d communication difficulties (35% vs. 78%; aPR = 0.65; 95% CI, 0.52-0.82) and \u201csome\u201d communication difficulties (62% vs. 78%; aPR = 0.89; 95% CI, 0.83-0.95) than those with no difficulty.<\/li>\n<li>      <b>Colorectal cancer:<\/b> Eligible adults who reported \u201csubstantial\u201d difficulty with self-care had significantly lower prevalence of any screening \u2014 colonoscopy or stool testing \u2014 than those who reported no difficulty (60% vs. 72%; aPR = 0.85; 95% CI, 0.76-0.95). <\/li>\n<\/ul>\n<p>\u201cBreast cancer screening is crucial for early detection, but cervical cancer screening and colorectal cancer screening with colonoscopy are preventive,\u201d Bandi said. \u201cSeeing such a significant proportion of eligible individuals with disabilities not being screened according to recommendations translates to a tremendous population burden \u2014 in the millions \u2014 of cancers that will not be prevented or detected early.\u201d<\/p>\n<p>There may be an opportunity for targeted intervention among adults who reported self-care disabilities, for whom \u201cshocking\u201d differences in screening adherence consistently emerged across all screenings studied, Bandi said.<\/p>\n<h2>\u2018A bright spot\u2019<\/h2>\n<p>The analysis yielded a potentially actionable silver lining.<\/p>\n<p>Results showed significantly greater utilization of colorectal cancer screening with stool testing among adults who reported higher levels of difficulty across several disability domains. <\/p>\n<p>Compared with adults who reported no difficulty, results showed higher stool testing prevalence among those who reported \u201csubstantial\u201d difficulty with mobility (22% vs. 16%; aPR = 1.24; 95% CI, 1.12-1.38), \u201csome\u201d difficulty with mobility (19% vs. 16%; aPR = 1.12; 95% CI, 1.03-1.21), \u201csome\u201d difficulty with self-care (24% vs. 16%; aPR = 1.28; 95% CI, 1.11-1.47) and \u201csome\u201d difficulty with vision (18% vs. 16%; aPR = 1.08; 95% CI, 1-1.17).<\/p>\n<p>This observation \u201ccompletely flipped the script\u201d with regard to screening disparities and shows the \u201cenormous potential\u201d of more accessible testing options \u2014 including stool testing and the first FDA-approved <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/womens-health-ob-gyn\/20250509\/fda-approves-first-athome-cervical-cancer-screening-device\" id=\"rId15\" target=\"_blank\">at-home cervical cancer screening device<\/a> \u2014 to mitigate screening disparities, Bandi said.<\/p>\n<p>\u201cI do think that is a bright spot, especially as more technologies are being made available for self-collection and at-home screening,\u201d she said. \u201cThese modalities may be more acceptable to individuals with disabilities, who may face barriers on several levels. If we offer individuals with disabilities more opportunities to screen at home, though, the clinical touchpoints must be in place to make sure they are not left hanging. The key will be closing the loop in terms of the continuum from detection to treatment.\u201d<\/p>\n<p>The investigators acknowledged study limitations. For example, self-reported information about screening prevalence is subject to recall and social desirability bias. Also, because the National Health Interview Survey only encompasses noninstitutionalized adults, findings may not be generalizable to adults in assisted living or other settings.<\/p>\n<p>Overall, however, the study provides valuable evidence across disability domains and difficulty levels that could inform strategies to reduce screening disparities, investigators concluded.<\/p>\n<p>\u201cIndividuals with disabilities face barriers at multiple levels,\u201d Bandi said. \u201cOpportunities to intervene at the policy level include making it easier for them to get to a clinic for screening, helping individuals who are uninsured or underinsured, or addressing social barriers such as financial or housing insecurity.\u201d<\/p>\n<p>Individual clinicians also play a vital role, Bandi said, pointing to communication about self-sampling or at-home testing as one entry point.<\/p>\n<p>\u201cHealthcare personnel are the gateway to preventive services,\u201d she said. \u201cIn the back of their minds, clinicians know this is an issue, but it has to become front of mind. This effort will require active outreach in a manner that is cognizant of the physical, psychological or social barriers that these individuals face.\u201d<\/p>\n<h2>For more information:<\/h2>\n<p>      <b>Priti Bandi, PhD,<\/b> can be reached at priti.bandi@cancer.org.<\/p>\n<div class=\"article__content--footer\">\n<div class=\"publisher-logo\">\n    <span>Published by:<\/span><br \/>\n    <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hot.svg?la=en&amp;h=24&amp;w=141&amp;hash=2F86D471C8514C0E334E329AA799E8B4\" class=\"logo-img\" height=\"24\" alt=\"hemonc today logo\" width=\"141\"\/>\n  <\/div>\n<div class=\"sources-references-disclosures\">\n<h3>Sources\/Disclosures<\/h3>\n<h2> Source: <\/h2>\n<p class=\"citation\">&#13;<br \/>\n  <a href=\"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.70557\" id=\"rId11\" target=\"_blank\">Mazzitelli N, et al. <i>Cancer<\/i>. 2026;doi:10.1002\/cncr.70557<\/a>.<\/p>\n<h2>References:<\/h2>\n<div class=\"disclosures\">\n<p>&#13;<br \/>\n        <strong> Disclosures: <\/strong>&#13;<br \/>\n        Four study authors report employment with American Cancer Society, which receives grants from private and corporate foundations for research outside the submitted work. The other authors report no relevant financial disclosures. American Cancer Society supported this study.&#13;\n      <\/p>\n<\/p><\/div>\n<\/div>\n<p><!-- Healio AI Widget --><\/p>\n<div class=\"healio-ai-component-inline\" data-no-ads=\"true\" data-module-track-category=\"Healio AI\" data-module-track-action=\"Click\" data-module-track-label=\"Access Healio Ai from component - News_AI Component - In-Content (all devices)\">\n<div class=\"healio-ai-content\">\n    <img decoding=\"async\" src=\"https:\/\/m3.healio.com\/~\/media\/images\/healio-ai\/healio-ai_logo.svg\" alt=\"Healio AI\" class=\"healio-ai-logo\"\/><\/p>\n<p><strong>Ask a clinical question<\/strong> and tap into <strong>Healio AI&#8217;s knowledge<\/strong> base.<\/p>\n<ul>&#13;<\/p>\n<li>PubMed, enrolling\/recruiting trials, guidelines<\/li>\n<p>&#13;<\/p>\n<li>Clinical Guidance, Healio CME, FDA news<\/li>\n<p>&#13;<\/p>\n<li>Healio&#8217;s exclusive daily news coverage of clinical data<\/li>\n<p>&#13;\n    <\/ul>\n<p>    <button class=\"healio-ai-button\" onclick=\"window.location.href=\" https:=\"\">Learn more<\/button>\n  <\/div>\n<\/div>\n<div class=\"email-alert-button-wrapper d-none\" data-component=\"EmailTopicAlert\" data-module=\"Subspecialty Email Topic Alerts Top\" data-manage-email-link=\"\/footer\/account-information\/my-account\/email-subscriptions-and-alerts#emailAlerts\">\n  <hidden data-setting-item=\"d265901d-6d37-49c7-a8f6-c7bf19a02509\"\/><br \/>\n  <hidden data-crm-source=\"Subspecialty Topic Alert\"\/><\/p>\n<div class=\"email-alert-button d-none\" data-topic-button=\"not-subscribed\">\n<p>&#13;<br \/>\n      <span data-module-track-action=\"Email Alerts TOP_Click_Healio News Article\" data-module-track-label=\"Email Alerts TOP_Healio News Article\">&#13;<br \/>\n        <i class=\"fas fa-plus-circle\"\/>&#13;<br \/>\n        Add topic to email alerts&#13;<br \/>\n      <\/span>&#13;\n    <\/p>\n<div class=\"email-alert-inner collapse u483252c67cd74a549285394306c311e2\">\n<div class=\"email-alert-dialogue\">\n<p>&#13;<br \/>\n          Receive an email when new articles are posted on <span data-content=\"topic-title\"\/>&#13;\n        <\/p>\n<div class=\"d-none\" data-sign-up-type=\"unknown\">\n          Please provide your email address to receive an email when new articles are posted on <span data-content=\"topic-title\"\/>.<\/p><\/div>\n<\/p><\/div>\n<p>      <button type=\"button\" class=\"btn btn-primary\" data-loading-text=\"Loading &lt;i class=\" fa=\"\" fa-spinner=\"\" fa-spin=\"\">&#8220;&#13;<br \/>\n              data-action=&#8221;subscribe&#8221;&gt;&#13;<br \/>\n        Subscribe&#13;<br \/>\n      <\/button>\n    <\/div>\n<\/p><\/div>\n<div class=\"d-none\" data-topic-modal=\"failed\">    <strong>We were unable to process your request. Please try again later. If you continue to have this issue please contact <a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260910\/mailto:customerservice@slackinc.com\">customerservice@slackinc.com<\/a>.<\/strong>  <\/p>\n<p><button data-dismiss=\"modal\" class=\"btn btn-primary btn-lg btn-block\">Back to Healio<\/button><\/p>\n<\/div>\n<\/div><\/div>\n<\/p><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260910\/cause-for-alarm-cancer-screening-rates-significantly-lower-for-adults-with-disabilities\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>September 10, 2026 6 min read &#13; &#13; &#13; Add topic to email alerts&#13; &#13; &#13; Receive an email when new articles are posted on &#13; Please provide your email address to receive an email when new articles are posted on . &#8220;&#13; data-action=&#8221;subscribe&#8221;&gt;&#13; Subscribe&#13; We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Adults with disabilities are significantly less likely to undergo routine cancer screenings. The largest gaps exist for those with self-care disabilities and those with greater disability-related difficulty. U.S. adults with disabilities are considerably less likely than those without them to undergo routine cancer screening, according to an analysis of national survey data. Researchers observed the largest screening gaps among individuals with self-care disabilities, such as difficulty dressing or bathing. &#13; &#13;&#13;&#13;&#13;&#13;&#13; &#13; &#13; &#13;&#13; Data derived from Mazzitelli N, et al. Cancer. 2026;doi:10.1002\/cncr.70557.&#13; &#13; Screening prevalence also declined as disability-related difficulty levels increased. For example, adults who reported \u201csubstantial\u201d difficulties with self-care appeared 37% less likely to undergo cervical cancer screening and 31% less likely to undergo breast cancer screening than adults with no difficulty. Screening also declined with greater difficulty in other disability domains, such as cognition, mobility and vision. Priti Bandi, PhD The findings are \u201ccause for alarm,\u201d according to senior author Priti Bandi, PhD, scientific director for cancer risk factors and screening surveillance research at American Cancer Society. \u201cWe know individuals with disabilities tend to have lower access to healthcare, but the magnitude of the disparities we observed \u2014 and the consistency with which they showed up across different domains \u2014 really surprised me,\u201d Bandi told Healio. \u201cBeing able to document this represents a call to action. This needs to be addressed.\u201d \u2018A clearer picture\u2019 More than one in four adults in the United States have some type of disability, according to CDC statistics. The most prevalent disabilities are those that affect cognition (13.9%), mobility (12.2%), independent living (7.7%), hearing (6.2%), vision (5.5%) and self-care (3.6%). All-cause mortality risk is more than double among individuals with disabilities than without, and risk for death due to chronic conditions \u2014 including cancer \u2014 also is higher, according to study background. Prior research showed people with cognitive, mobility or intellectual disabilities are less adherent to cancer screening. This may be due to barriers related to clinic access (eg, lack of transportation or insurance), personal factors (eg, fear of embarrassment or distrust of the medical system) or difficulties completing the physical aspects of screening, Bandi said. However, evidence about how adherence varies based on disability domains and related difficulty is limited. \u201cHaving a clearer picture about how disabilities impact receipt of cancer preventive services across disability domains \u2014 not just physical, but also the more \u2018invisible\u2019 disabilities related to cognition and communication \u2014 is critical to help develop interventions that are relevant and effective for these populations,\u201d Bandi said. Bandi and colleagues \u2014 including lead author Natalia Mazzitelli, MPH \u2014 evaluated self-reported adherence to U.S. Preventive Services Task Force recommendations for breast, cervical and colorectal cancer screening among adults with disabilities vs. those without, calculating adjusted prevalence ratios (aPR) to make the comparisons. The researchers pooled data from the National Health Interview Survey in 2021 and 2023. Each survey collected a broad range of data about health topics from more than 29,000 noninstitutionalized adults. Investigators assessed self-reported screening rates based on six functioning domains \u2014 vision, hearing, mobility, communication, cognition and self-care. Because there often is overlap between domains, researchers analyzed the degree of difficulty for each one \u2014 using the Washington Group Composite Disability Indicator, a validated tool that classifies severity of functional limitations \u2014 to further clarify individuals at greatest risk for screening nonadherence. Key findings The researchers identified survey respondents with disabilities eligible for breast screening (n = 1,712; population weighted, n = 6.02 million), cervical screening (n = 1,147, population weighted, n = 5.1 million) and colorectal screening (n = 3,106; population weighted, n = 11.17 million). Results revealed the following trends by screening type: Breast cancer: Eligible adults with \u201csubstantial\u201d difficulties across multiple disability domains had lower screening prevalence than those who reported no difficulties, with the lowest prevalence in the self-care (52% vs. 79%; aPR = 0.69; 95% CI, 0.58-0.82), vision (62% vs. 79%; aPR = 0.83; 95% CI, 0.75-0.91) and mobility (68% vs. 79%; aPR = 0.89; 95% CI, 0.85-0.93) domains. Results showed significantly lower screening prevalence among those with \u201csome\u201d difficulties vs. no difficulty in self-care (71% vs. 79%; aPR = 0.93; 95% CI, 0.88-0.99), cognition (75% vs. 79%; aPR = 0.96; 95% CI, 0.94-0.99) and vision (75% vs. 79%; aPR = 0.96; 95% CI, 0.94-0.99). Cervical cancer: Eligible adults who reported \u201csubstantial\u201d difficulties across multiple disability domains had lower screening prevalence than those who reported no difficulties, with the lowest prevalence in the self-care (37% vs. 78%; aPR = 0.63; 95% CI, 0.51-0.78), vision (64% vs. 78%; aPR = 0.89; 95% CI, 0.8-0.98), mobility (65% vs. 78%; aPR = 0.88; 95% CI, 0.82-0.94) and cognitive (64% vs. 78%; aPR = 0.91; 95% CI, 0.85-0.98) domains. Results showed significantly lower screening prevalence among those with \u201csubstantial\u201d communication difficulties (35% vs. 78%; aPR = 0.65; 95% CI, 0.52-0.82) and \u201csome\u201d communication difficulties (62% vs. 78%; aPR = 0.89; 95% CI, 0.83-0.95) than those with no difficulty. Colorectal cancer: Eligible adults who reported \u201csubstantial\u201d difficulty with self-care had significantly lower prevalence of any screening \u2014 colonoscopy or stool testing \u2014 than those who reported no difficulty (60% vs. 72%; aPR = 0.85; 95% CI, 0.76-0.95). \u201cBreast cancer screening is crucial for early detection, but cervical cancer screening and colorectal cancer screening with colonoscopy are preventive,\u201d Bandi said. \u201cSeeing such a significant proportion of eligible individuals with disabilities not being screened according to recommendations translates to a tremendous population burden \u2014 in the millions \u2014 of cancers that will not be prevented or detected early.\u201d There may be an opportunity for targeted intervention among<\/p>\n","protected":false},"author":1,"featured_media":3643,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3642","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/3642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3642"}],"version-history":[{"count":0,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/3642\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/media\/3643"}],"wp:attachment":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}